LUMOS PHARMA INC shareholders Q3 2023

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 36 filers reported holding LUMOS PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

LUMOS PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Acuitas Investments, LLC 125,242$413,2990.24%
Lion Point Capital, LP 90,794$299,6200.13%
Greenwich Wealth Management LLC 76,341$2520.03%
Wealth Advisors of Iowa, LLC 11,699$38,6060.03%
Marquette Asset Management, LLC 25,760$85,0080.02%
Key FInancial Inc 10,927$36,0590.01%
Paladin Advisory Group, LLC 4,387$14,4770.01%
Blackstone Inc. 468,145$1,544,8790.01%
Leucadia National 120,651$398,1480.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$157,2220.00%
Renaissance Technologies 226,714$7480.00%
West Financial Advisors, LLC 784$2,5880.00%
Private Advisor Group, LLC 20,013$66,0430.00%
OSAIC HOLDINGS, INC. 7,652$25,2480.00%
DIMENSIONAL FUND ADVISORS LP 15,564$51,3930.00%
BANK OF AMERICA CORP /DE/ 1,800$5,9400.00%
WELLS FARGO & COMPANY/MN 416,549$1,374,6110.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 150$4950.00%
GEODE CAPITAL MANAGEMENT, LLC 47,596$157,0980.00%
External links

This page lists LUMOS PHARMA INC's shareholders in Q3 2023. To view LUMOS PHARMA INC's shareholder history, click here.